SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics
INGN 7.065+0.8%3:45 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (555)8/7/2006 2:37:25 PM
From: JibacoaRead Replies (1) of 802
 
Introgen Therapeutics, Inc. Second Quarter 2006 Earnings Conference Call
Monday August 7, 2:30 pm ET

AUSTIN, Texas, Aug. 7 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN - News), a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases, will hold its quarterly conference call to discuss second quarter results on Wednesday, August 9, 2006, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time).

This call is being webcast by Thomson/CCBN and can be accessed at Introgen's Web site at www.introgen.com.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.

Snip

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext